findmyKOL

Andras Perl, MD

Enriched profile

SUNY Distinguished Professor of Medicine, Biochemistry & Molecular Biology, and Microbiology & Immunology; Chief, Division of Rheumatology; Vice Chair for Research, Department of Medicine; Director, Rheumatology Fellowship; Co-Director, MD-PhD Training Program · SUNY Upstate Medical University

ORCIDNPI
Region🇺🇸 Syracuse, NY · Northeast · United StatesSpecialtyRheumatologyFocusLupus (SLE)
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2023–2025NIH funding1996–2026

Andras Perl is SUNY Distinguished Professor of Medicine, Biochemistry & Molecular Biology, and Microbiology & Immunology; Chief, Division of Rheumatology; Vice Chair for Research, Department of Medicine; Director, Rheumatology Fellowship; Co-Director, MD-PhD Training Program at SUNY Upstate Medical University. OpenAlex indexes 285 publications with 21,719 citations (h-index 66); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.

Data verified 17 Aug 2026

Overview

Updated 27 Aug 2026

Andras Perl, MD, is SUNY Distinguished Professor of Medicine, Biochemistry & Molecular Biology, and Microbiology & Immunology at SUNY Upstate Medical University, Norton College of Medicine, Syracuse, NY. The public record shows 285 publications with 21,719 citations (h-index 66), centered on Lupus (SLE). It also documents an investigator role on 2 registered clinical trials, industry payments reported by 1 companies, 11 NIH-funded awards (1996–2026).

  • Most recent indexed publication: 2026 · Nature reviews. Rheumatology
  • Top research focus: Lupus (SLE)
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lupus (SLE)2 trialsST Elevation Myocardial Infarction2 trialsErythema2 trialsGlomerular Disease1 trialNephritis1 trialLupus Vasculitis, Central Nervous System1 trial

Research focus

OpenAlex concept fingerprint
Lupus (SLE)

Drugs & molecules

across trials, industry payments and publications
Tremfyageneric · GuselkumabClinical trialsIndustry payments2Publications

Works with

trial sponsors and companies reporting payments
Janssen Biotech, Inc.Clinical trialsIndustry payments2Lupus Research AllianceClinical trials1Industry paymentsState University of New York - Upstate Medical UniversityClinical trials1Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
285publications

Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.

21,719citations

Total citations across indexed works.

66h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
1companies · 2023–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
11NIH grants · 1996–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

1 company reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Antiparasitic

    36.4%
    Antimalarial36.4%
    Hydroxychloroquine Sulfate100%
    Part D45 patients
  • Cancer & immunology

    26.4%
    Folate Analog Metabolic Inhibitor10.3%
    Methotrexate100%
    Part D17 patients
    B Lymphocyte Stimulator-specific Inhibitor4.4%
    Benlysta100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    18.3%
    Corticosteroid18.3%
    Prednisone100%
    Part D21 patients
3 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

11 NIH research awards on record, funded 19962026 per NIH RePORTER. The latest:

54 more award records behind the reveal.Reveal →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/cv/andras-perl-md-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/andras-perl-283b4a64

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • LinkedIn

    linkedin.com/in/andras-perl-731aba4

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
2 more verified accounts behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/UpstateMedicalUniversity/photos/dr-andras-perl-center-is-one-of-three-upstate-medical-university-faculty-members/10155692953537965

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • Other

    upstate.edu/informed/2020/091620-perl-interview.php

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →upstate.edu
  • Other

    upstate.edu/informed/2024/032924-perl-marte-podcast.php

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →upstate.edu
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Semmelweis University, Budapest, Hungary

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com
  • PhD

    Semmelweis University, Budapest, Hungary

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iomcworld.org
  • Rheumatology/Immunology Fellowship

    University of Rochester

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iomcworld.org

Editorial & leadership roles

journal and society appointments
  • Editor-in-Chief

    ACR Open Rheumatology (American College of Rheumatology / Wiley journal), since ~January 2024

    2024
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →the-rheumatologist.org
  • Chief

    Division of Rheumatology & Clinical Immunology, SUNY Upstate Medical University

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →upstate.edu
  • Director

    Rheumatology Fellowship, SUNY Upstate Medical University

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →upstate.edu
3 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances
  • Podcast guest

    'Researchers probe how lupus develops and persists,' The Informed Patient Podcast, SUNY Upstate

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →upstate.edu
  • Podcast guest

    'Drug trial aims to find new treatment for lupus,' The Informed Patient Podcast, SUNY Upstate

    2020
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →upstate.edu
  • Radio interview segment

    HealthLink on Air, SUNY Upstate Medical University

    2020
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →upstate.edu
2 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.